- Published on
Infectious Disease - Brain Abscess
BRAIN ABSCESS
FUNDAMENTAL DESCRIPTION
A brain abscess is a localized accumulation of purulent material inside the brain parenchyma resulting from an infectious agent, such as bacteria, fungus, or protozoa. The formation may exhibit a distinct abscess wall or comprise an inflammatory condition (cerebritis).
Epidemiology
Frequency
• Uncommon infection, present in 0.2–1.3% of extensive postmortem studies, and in 1 out of 10,000 hospital admissions. • 25% of brain abscesses occur in pediatric patients. • Median age of infection: 30–45 years.
RISK FACTORS • Sinusitis • Otitis media • Inadequate dental hygiene
• Endocarditis • Bacteremia due to indwelling central lines and intravenous drug usage • Osler–Weber–Rendu syndrome
• Prior brain injury • Immunocompromised state • Cyanotic congenital heart disease
• Intrapulmonary shunting in individuals with arteriovenous malformations
GENERAL PREVENTION • Sinusitis and otitis must be addressed in all patients.
• Proper dental hygiene is essential in the management of apical abscesses, particularly in the upper molars.
PATHOPHYSIOLOGY • Infection may access the brain through the following mechanisms:
- Direct transmission from the sinuses, orbit, dental structures, mastoid, middle ear, and meninges – Post-trauma or neurosurgical intervention – Hematogenous dissemination
ETIOLOGY • The characteristics of the organisms present in the infection frequently
pertains to the method of transmission:
• Middle ear, paranasal sinuses, odontogenic infections - Mixed infections involving anaerobes, microaerophilic streptococci, viridans streptococci, Streptococcus milleri, S. pneumoniae (infrequent), Haemophilus, Fusobacterium, Prevotella melaninogenica, Enterobacteriaceae, Pseudomonas
• Trauma and postoperative considerations: Staphylococcus aureus – Pseudomonas – Additional gram-negative bacteria
– Propionibacterium • Hematogenous:
– Staphylococcus aureus – Salmonella
– Listeria monocytogenes
- Streptococci (notably Streptococcus viridans) Klebsiella pneumoniae
– Escherichia coli, Proteus species – Pseudomonas – Bacteroides species (including Bacteroides fragilis) – Actinomyces – Fungi
• Immunocompromised individuals: – Toxoplasma gondii – Listeria species – Rhodococcus equi
Nocardia asteroides
Aspergillus species, Cryptococcus neoformans, Coccidioides immitis, Candida species, Zygomycetes, Cladosporium trichoides, Curvularia species.
• Immigrants originating from endemic nations: – Taenia solium – Entamoeba histolytica – Schistosoma japonicum – Paragonimus spp.
DIAGNOSIS
The clinical signs are often modest and nonspecific.
• Common symptoms consist of headache lasting less than two weeks (75% of cases), neck stiffness (25%), alterations in mental state, nausea, and vomiting.
• Low-grade fevers may occur in 45–50% of cases.
• Focal neurological abnormalities seen in 50% of cases
• Seizures occur in 25% of cases and may serve as the primary indication for CT screening.
Deficits in the third and sixth cranial nerves, along with papilledema, signify elevated intracranial pressure and cerebral edema. Diagnosis is contingent upon the abscess's location, the causative organism, and any prior conditions that may have contributed to its formation.
DIAGNOSTIC TESTS AND INTERPRETATION Laboratory
• The white blood cell count is high in 60–70% of cases.
• ESR may elevate in 90% of cases.
• Lumbar puncture poses significant risks, particularly in patients exhibiting focal neurological symptoms. If the cerebrospinal fluid mimics that of bacterial meningitis, one may assume a ruptured abscess.
the ventricle
• Microbiological diagnosis • Positive blood cultures • Stereotactic abscess aspiration, cultures, and specific stains • 16S ribosomal sequencing of the aspirate • Serology: Toxoplasmosis, neurocysticercosis
Imaging
CT and MRI are essential diagnostic modalities.
Gadolinium-enhanced MRI provides superior visualization of the brainstem, whereas diffusion-weighted MRI is employed to distinguish between brain abscesses and neoplastic lesions.
• Serial scans must be conducted, particularly when empirical treatment is used.
Ring lesions may endure for a duration of 3 to 4 months, even with appropriate treatment.
Diagnostic Procedures and Additional Methods
• Stereotactic aspiration: The preferred method when the abscess is readily accessible and exceeds 2.5 cm in diameter. • Craniotomy with aspiration: Indicated in regions requiring direct sight of blood vessels when the abscess measures over 2.5 cm in diameter.
DIFFERENTIAL DIAGNOSIS • Epidural and subdural empyema • Septic dural sinus thrombosis • Mycotic aneurysms • Septic cerebral emboli with infarcts • Acute focal necrotizing encephalitis • Metastatic or primary brain tumors • Pyogenic meningitis • Hematoma • Radiation necrosis
ADDITIONAL TREATMENT
Comprehensive Strategies
The antibiotic treatment is contingent upon the probable source of the infection.
• Commence empiric antibiotics promptly following the acquisition of the requisite specimens.
The culture and sensitivity of any isolated organism should inform the selection of the antibiotic treatment.
• For empirical management of an abscess originating from oral, otogenic, or sinus sources: Administer cefotaxime 2 g intravenously every 4 hours or ceftriaxone 2 g intravenously every 12 hours, alongside metronidazole 7.5 mg/kg intravenously every 8 hours (not to surpass 4 g per day; utilize 15 mg/kg as an initial loading dose).
• As an alternative for an oral source, administer penicillin G at a dosage of 24 million units per day in divided doses every 4 hours, and metronidazole at 7.5 mg/kg intravenously every 6 hours.
For suspected hematogenous dissemination, administer vancomycin (30 mg/kg in two split doses) alongside metronidazole and either cefotaxime or ceftriaxone at the specified dosages.
Postsurgical infections should be empirically managed with vancomycin at a dosage of 30 mg/kg administered in two separate doses, alongside ceftazidime (2 g intravenously every 8 hours) or cefepime (2 g intravenously every 8 hours). In cases where cultures indicate Methicillin-Sensitive Staphylococcus aureus (MSSA), substitute vancomycin with nafcillin or oxacillin (2 g IV every 4 hours) due to superior central nervous system penetration.
• For abscesses resulting from penetrating trauma, administer empirical treatment with vancomycin and either ceftriaxone or cefotaxime at the specified dosages. Substitute vancomycin with nafcillin or oxacillin upon confirmation of MSSA.
• A duration of 6 to 8 weeks, or longer, of intravenous therapy is required, accompanied by further CT scan evaluations.
• Steroids should be administered if mass effect is evident and mental status is impaired.
Surgical intervention serves both diagnostic and therapeutic purposes. Aspiration is a straightforward operation conducted under local anesthetic that facilitates prompt alleviation of elevated intracranial pressure.
New methodologies for the management of brain abscesses encompass ioMRI-guided aspiration and ioMRI-guided resection.
COMPLICATIONS
Cerebral herniation may manifest in 15–20% of patients. High morbidity correlates with persisting neurological impairments in patients with a history of brain abscesses.
Hemiparesis has been documented in 50%. Epilepsy occurs in less than 50%. The primary determinant of death is the neurological condition at the time of presentation.
CONTINUED MANAGEMENT POST-TREATMENT SUGGESTIONS
Patients frequently necessitate consecutive CT or MRI scans for a minimum duration of one year after the conclusion of antibiotic treatment.
BRAIN ABSCESS
FUNDAMENTAL DESCRIPTION
A brain abscess is a localized accumulation of purulent material inside the brain parenchyma resulting from an infectious agent, such as bacteria, fungus, or protozoa. The formation may exhibit a distinct abscess wall or comprise an inflammatory condition (cerebritis).
Epidemiology
Frequency
• Uncommon infection, present in 0.2–1.3% of extensive postmortem studies, and in 1 out of 10,000 hospital admissions. • 25% of brain abscesses occur in pediatric patients. • Median age of infection: 30–45 years.
RISK FACTORS • Sinusitis • Otitis media • Inadequate dental hygiene
• Endocarditis • Bacteremia due to indwelling central lines and intravenous drug usage • Osler–Weber–Rendu syndrome
• Prior brain injury • Immunocompromised state • Cyanotic congenital heart disease
• Intrapulmonary shunting in individuals with arteriovenous malformations
GENERAL PREVENTION • Sinusitis and otitis must be addressed in all patients.
• Proper dental hygiene is essential in the management of apical abscesses, particularly in the upper molars.
PATHOPHYSIOLOGY • Infection may access the brain through the following mechanisms:
- Direct transmission from the sinuses, orbit, dental structures, mastoid, middle ear, and meninges – Post-trauma or neurosurgical intervention – Hematogenous dissemination
ETIOLOGY • The characteristics of the organisms present in the infection frequently
pertains to the method of transmission:
• Middle ear, paranasal sinuses, odontogenic infections - Mixed infections involving anaerobes, microaerophilic streptococci, viridans streptococci, Streptococcus milleri, S. pneumoniae (infrequent), Haemophilus, Fusobacterium, Prevotella melaninogenica, Enterobacteriaceae, Pseudomonas
• Trauma and postoperative considerations: Staphylococcus aureus – Pseudomonas – Additional gram-negative bacteria
– Propionibacterium • Hematogenous:
– Staphylococcus aureus – Salmonella
– Listeria monocytogenes
- Streptococci (notably Streptococcus viridans) Klebsiella pneumoniae
– Escherichia coli, Proteus species – Pseudomonas – Bacteroides species (including Bacteroides fragilis) – Actinomyces – Fungi
• Immunocompromised individuals: – Toxoplasma gondii – Listeria species – Rhodococcus equi
Nocardia asteroides
Aspergillus species, Cryptococcus neoformans, Coccidioides immitis, Candida species, Zygomycetes, Cladosporium trichoides, Curvularia species.
• Immigrants originating from endemic nations: – Taenia solium – Entamoeba histolytica – Schistosoma japonicum – Paragonimus spp.
DIAGNOSIS
The clinical signs are often modest and nonspecific.
• Common symptoms consist of headache lasting less than two weeks (75% of cases), neck stiffness (25%), alterations in mental state, nausea, and vomiting.
• Low-grade fevers may occur in 45–50% of cases.
• Focal neurological abnormalities seen in 50% of cases
• Seizures occur in 25% of cases and may serve as the primary indication for CT screening.
Deficits in the third and sixth cranial nerves, along with papilledema, signify elevated intracranial pressure and cerebral edema. Diagnosis is contingent upon the abscess's location, the causative organism, and any prior conditions that may have contributed to its formation.
DIAGNOSTIC TESTS AND INTERPRETATION Laboratory
• The white blood cell count is high in 60–70% of cases.
• ESR may elevate in 90% of cases.
• Lumbar puncture poses significant risks, particularly in patients exhibiting focal neurological symptoms. If the cerebrospinal fluid mimics that of bacterial meningitis, one may assume a ruptured abscess.
the ventricle
• Microbiological diagnosis • Positive blood cultures • Stereotactic abscess aspiration, cultures, and specific stains • 16S ribosomal sequencing of the aspirate • Serology: Toxoplasmosis, neurocysticercosis
Imaging
CT and MRI are essential diagnostic modalities.
Gadolinium-enhanced MRI provides superior visualization of the brainstem, whereas diffusion-weighted MRI is employed to distinguish between brain abscesses and neoplastic lesions.
• Serial scans must be conducted, particularly when empirical treatment is used.
Ring lesions may endure for a duration of 3 to 4 months, even with appropriate treatment.
Diagnostic Procedures and Additional Methods
• Stereotactic aspiration: The preferred method when the abscess is readily accessible and exceeds 2.5 cm in diameter. • Craniotomy with aspiration: Indicated in regions requiring direct sight of blood vessels when the abscess measures over 2.5 cm in diameter.
DIFFERENTIAL DIAGNOSIS • Epidural and subdural empyema • Septic dural sinus thrombosis • Mycotic aneurysms • Septic cerebral emboli with infarcts • Acute focal necrotizing encephalitis • Metastatic or primary brain tumors • Pyogenic meningitis • Hematoma • Radiation necrosis
ADDITIONAL TREATMENT
Comprehensive Strategies
The antibiotic treatment is contingent upon the probable source of the infection.
• Commence empiric antibiotics promptly following the acquisition of the requisite specimens.
The culture and sensitivity of any isolated organism should inform the selection of the antibiotic treatment.
• For empirical management of an abscess originating from oral, otogenic, or sinus sources: Administer cefotaxime 2 g intravenously every 4 hours or ceftriaxone 2 g intravenously every 12 hours, alongside metronidazole 7.5 mg/kg intravenously every 8 hours (not to surpass 4 g per day; utilize 15 mg/kg as an initial loading dose).
• As an alternative for an oral source, administer penicillin G at a dosage of 24 million units per day in divided doses every 4 hours, and metronidazole at 7.5 mg/kg intravenously every 6 hours.
For suspected hematogenous dissemination, administer vancomycin (30 mg/kg in two split doses) alongside metronidazole and either cefotaxime or ceftriaxone at the specified dosages.
Postsurgical infections should be empirically managed with vancomycin at a dosage of 30 mg/kg administered in two separate doses, alongside ceftazidime (2 g intravenously every 8 hours) or cefepime (2 g intravenously every 8 hours). In cases where cultures indicate Methicillin-Sensitive Staphylococcus aureus (MSSA), substitute vancomycin with nafcillin or oxacillin (2 g IV every 4 hours) due to superior central nervous system penetration.
• For abscesses resulting from penetrating trauma, administer empirical treatment with vancomycin and either ceftriaxone or cefotaxime at the specified dosages. Substitute vancomycin with nafcillin or oxacillin upon confirmation of MSSA.
• A duration of 6 to 8 weeks, or longer, of intravenous therapy is required, accompanied by further CT scan evaluations.
• Steroids should be administered if mass effect is evident and mental status is impaired.
Surgical intervention serves both diagnostic and therapeutic purposes. Aspiration is a straightforward operation conducted under local anesthetic that facilitates prompt alleviation of elevated intracranial pressure.
New methodologies for the management of brain abscesses encompass ioMRI-guided aspiration and ioMRI-guided resection.
COMPLICATIONS
Cerebral herniation may manifest in 15–20% of patients. High morbidity correlates with persisting neurological impairments in patients with a history of brain abscesses.
Hemiparesis has been documented in 50%. Epilepsy occurs in less than 50%. The primary determinant of death is the neurological condition at the time of presentation.
CONTINUED MANAGEMENT POST-TREATMENT SUGGESTIONS
Patients frequently necessitate consecutive CT or MRI scans for a minimum duration of one year after the conclusion of antibiotic treatment.
0 Comments
